| Primary |
| Acne |
58.3% |
| Product Used For Unknown Indication |
13.7% |
| Cognitive Disorder |
3.5% |
| Rosacea |
3.1% |
| Pyrexia |
2.7% |
| Drug Use For Unknown Indication |
2.0% |
| Rheumatoid Arthritis |
1.8% |
| Age-related Macular Degeneration |
1.6% |
| Folliculitis |
1.6% |
| Infection |
1.4% |
| Staphylococcal Infection |
1.4% |
| Genital Infection |
1.2% |
| Infective Pulmonary Exacerbation Of Cystic Fibrosis |
1.2% |
| Cutaneous Sarcoidosis |
1.0% |
| Prophylaxis |
1.0% |
| Pyoderma Gangrenosum |
1.0% |
| Dermatitis |
0.8% |
| Pulmonary Air Leakage |
0.8% |
| Pustular Psoriasis |
0.8% |
| Relapsing-remitting Multiple Sclerosis |
0.8% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
9.2% |
| Polyarteritis Nodosa |
9.2% |
| Vomiting |
8.1% |
| Pyrexia |
7.6% |
| Weight Decreased |
7.0% |
| Lupus-like Syndrome |
6.5% |
| Pigmentation Disorder |
6.5% |
| Urticaria |
4.9% |
| Skin Discolouration |
4.3% |
| Vasculitis Necrotising |
4.3% |
| Nausea |
3.8% |
| Systemic Lupus Erythematosus |
3.8% |
| Tachycardia |
3.8% |
| Thyroid Disorder |
3.8% |
| Arthralgia |
3.2% |
| Papillary Thyroid Cancer |
3.2% |
| Benign Intracranial Hypertension |
2.7% |
| Rash |
2.7% |
| Unevaluable Event |
2.7% |
| Vasculitis |
2.7% |
|
| Secondary |
| Pneumonia |
12.7% |
| Pseudomonas Infection |
11.1% |
| Mycobacterium Abscessus Infection |
10.6% |
| Product Used For Unknown Indication |
9.7% |
| Drug Use For Unknown Indication |
7.7% |
| Acne |
6.2% |
| Pyrexia |
6.0% |
| Prophylaxis |
4.4% |
| Staphylococcal Infection |
3.8% |
| Colorectal Cancer |
3.6% |
| Rheumatoid Arthritis |
3.4% |
| Infection |
2.7% |
| Interstitial Lung Disease |
2.6% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Lobar Pneumonia |
2.4% |
| Pulmonary Mycosis |
2.4% |
| Disseminated Intravascular Coagulation |
2.2% |
| Multiple Myeloma |
2.1% |
| Hypertension |
2.1% |
| Bacteraemia |
1.9% |
|
| Tachycardia |
15.4% |
| Interstitial Lung Disease |
7.7% |
| Pyrexia |
6.4% |
| Stevens-johnson Syndrome |
5.1% |
| Viral Infection |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Hepatic Function Abnormal |
4.5% |
| Pancytopenia |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Toxic Skin Eruption |
4.5% |
| Diarrhoea |
3.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.8% |
| Platelet Count Decreased |
3.8% |
| Streptococcal Infection |
3.8% |
| Syncope |
3.8% |
| Colitis Ulcerative |
3.2% |
| Decreased Appetite |
3.2% |
| Pneumonia |
3.2% |
| Rash |
3.2% |
|
| Concomitant |
| Acne |
15.0% |
| Product Used For Unknown Indication |
13.3% |
| Drug Use For Unknown Indication |
13.0% |
| Rheumatoid Arthritis |
7.6% |
| Colorectal Cancer |
7.5% |
| Prophylaxis |
7.5% |
| Pain |
5.3% |
| Non-small Cell Lung Cancer |
3.8% |
| Hypertension |
3.6% |
| Head And Neck Cancer |
3.3% |
| Pneumonia |
3.2% |
| Contraception |
2.8% |
| Nausea |
2.2% |
| Depression |
2.1% |
| Anxiety |
1.8% |
| Insomnia |
1.8% |
| Rash |
1.7% |
| Infection |
1.7% |
| Infection Prophylaxis |
1.6% |
| Pyrexia |
1.4% |
|
| Vomiting |
14.5% |
| Pulmonary Embolism |
8.6% |
| Pain |
6.8% |
| White Blood Cell Count Decreased |
6.6% |
| Pyrexia |
6.0% |
| Weight Decreased |
5.6% |
| Deep Vein Thrombosis |
5.0% |
| Pneumonia |
5.0% |
| Rash |
5.0% |
| Interstitial Lung Disease |
4.6% |
| Weight Increased |
4.6% |
| Renal Failure Acute |
3.8% |
| Death |
3.6% |
| Tachycardia |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Nausea |
3.0% |
| Thrombosis |
2.8% |
| Hypotension |
2.6% |
| Injury |
2.6% |
| Renal Impairment |
2.6% |
|
| Interacting |
| Acne |
15.4% |
| Hiv Infection |
15.4% |
| Ankylosing Spondylitis |
6.2% |
| Bipolar Disorder |
6.2% |
| Breast Cancer |
6.2% |
| Depression |
6.2% |
| Headache |
6.2% |
| Product Used For Unknown Indication |
6.2% |
| Cervix Carcinoma |
3.1% |
| Convulsion |
3.1% |
| Drug Use For Unknown Indication |
3.1% |
| Hypersensitivity |
3.1% |
| Hypothyroidism |
3.1% |
| Localised Infection |
3.1% |
| Muscle Spasms |
3.1% |
| Pain |
3.1% |
| Post-traumatic Epilepsy |
3.1% |
| Migraine |
1.5% |
| Migraine Prophylaxis |
1.5% |
| Prophylaxis |
1.5% |
|
| Hypertriglyceridaemia |
20.0% |
| Urticaria |
20.0% |
| Drug Level Decreased |
10.0% |
| Nervousness |
10.0% |
| Personality Disorder |
10.0% |
| Tachycardia |
10.0% |
| Tremor |
10.0% |
| Withdrawal Syndrome |
10.0% |
|
